A 2023 systematic review published in Cureus has confirmed that ketamine offers rapid, short-term symptom…
Read More
In the open-label trial Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive…
Read More
© 2023-2025. AVYIA Health. All rights reserved.